Literature DB >> 2293749

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.

T A Miettinen1, R S Tilvis, Y A Kesäniemi.   

Abstract

To investigate the regulation of serum levels of cholesterol precursor sterols and plant sterols, these noncholesterol sterols, fatty acids, and various parameters of cholesterol metabolism were analyzed in 63 volunteers from a randomly selected Finnish male population sample of 100 subjects, aged 50 years, who had normal dietary habits. Serum levels of cholesterol precursors, desmosterol and lathosterol (in terms of micrograms/mg cholesterol), were negatively related to both the fractional and absolute absorption of dietary cholesterol and serum high density lipoprotein (HDL) cholesterol, and positively related to overall cholesterol synthesis and serum very low density lipoprotein (VLDL) cholesterol. Serum levels of the plant sterols, campesterol and sitosterol, exhibited positive correlations with the polyunsaturated/saturated fatty acid ratio of dietary fat, the linoleic acid contents of plasma and dietary lipids, the amount of dietary plant sterols (as indicated by fecal output), fractional and absolute absorption of dietary cholesterol, and HDL cholesterol, but were inversely related to the overall cholesterol synthesis and VLDL cholesterol. Stepwise multiple regression analysis revealed that the serum level of campesterol was associated with fractional cholesterol absorption, dietary plant sterols, and biliary cholesterol secretion, and that of sitosterol with dietary plant sterols, cholesterol synthesis, fractional cholesterol absorption, and biliary cholesterol secretion. Thus, the serum non-cholesterol sterols are significant indicators of cholesterol absorption and synthesis even under basal conditions and, since gas liquid chromatographic determination of these sterols is quite simple, their measurement may be valuable for monitoring cholesterol metabolism in large-scale epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293749     DOI: 10.1093/oxfordjournals.aje.a115479

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  119 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis.

Authors:  Lily Jakulj; Maud N Vissers; Michael W T Tanck; Barbara A Hutten; Frans Stellaard; John J P Kastelein; Geesje M Dallinga-Thie
Journal:  J Lipid Res       Date:  2010-06-25       Impact factor: 5.922

3.  Ileal pouch-anal anastomosis, conventional ileostomy and ileorectal anastomosis modify cholesterol metabolism.

Authors:  Markku J Nissinen; Helena Gylling; Heikki J Järvinen; Tatu A Miettinen
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.

Authors:  T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  A moderate intake of phytosterols from habitual diet affects cholesterol metabolism.

Authors:  T Sanclemente; I Marques-Lopes; M Fajó-Pascual; M Cofán; E Jarauta; E Ros; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

6.  Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; David M Maahs; Lawrence M Dolan; Amy S Shah; Clary B Clish; Sudha B Biddinger
Journal:  Pediatr Diabetes       Date:  2020-09-15       Impact factor: 4.866

Review 7.  Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications.

Authors:  Katriina Nemes; Fredrik Åberg; Helena Gylling; Helena Isoniemi
Journal:  World J Hepatol       Date:  2016-08-08

8.  Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Huber; Kathrin Hochegger; Wilfried Schgoer; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

9.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

10.  Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort.

Authors:  Verónica Escurriol; Montserrat Cofán; Concepción Moreno-Iribas; Nerea Larrañaga; Carmen Martínez; Carmen Navarro; Laudina Rodríguez; Carlos A González; Dolores Corella; Emilio Ros
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.